Genus (LON:GNS - Get Free Report)'s stock had its "not rated" rating reaffirmed by Shore Capital in a note issued to investors on Friday, Marketbeat.com reports.
Genus Stock Performance
Genus stock traded up GBX 74 ($0.93) during mid-day trading on Friday, reaching GBX 1,718 ($21.54). 83,971 shares of the company traded hands, compared to its average volume of 119,075. Genus has a fifty-two week low of GBX 1,478 ($18.53) and a fifty-two week high of GBX 2,378 ($29.81). The firm's fifty day moving average is GBX 1,955.79 and its two-hundred day moving average is GBX 1,837.12. The company has a debt-to-equity ratio of 53.54, a current ratio of 1.80 and a quick ratio of 1.08. The company has a market capitalization of £1.13 billion, a price-to-earnings ratio of 14,316.67, a price-to-earnings-growth ratio of 2.87 and a beta of 0.37.
Insider Transactions at Genus
In related news, insider Jorgen Kokke sold 2,186 shares of the firm's stock in a transaction that occurred on Monday, September 16th. The shares were sold at an average price of GBX 1,956 ($24.52), for a total value of £42,758.16 ($53,601.81). Also, insider Iain Ferguson purchased 3,000 shares of the business's stock in a transaction on Thursday, September 5th. The stock was acquired at an average price of GBX 1,800 ($22.56) per share, for a total transaction of £54,000 ($67,694.62). Corporate insiders own 0.75% of the company's stock.
About Genus
(
Get Free Report)
Genus plc operates as an animal genetics company in North America, Latin America, the United Kingdom, rest of Europe, the Middle East, Russia, Africa, and Asia. The company operates through three segments: Genus PIC, Genus ABS, and Genus Research and Development. It sells breeding pigs and semen to breed pigs with various characteristics for pork production under the PIC brand.
Featured Stories
Before you consider Genus, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Genus wasn't on the list.
While Genus currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
